Editor’s Note: Set against the scenic backdrop of Qingdao’s coastline, the 11th Qingdao Breast Disease Conference, alongside the 9th “Langya Forum,” was successfully held from September 10 to 14, 2025. The event brought together leading experts and emerging voices from across China and abroad to share cutting-edge research, explore the latest diagnostic and therapeutic strategies, and shape the future of breast disease management. Oncology Frontier invited Professor Haibo Wang, Conference Chair and Director of the Breast Disease Hospital at the Affiliated Hospital of Qingdao University, to discuss this year’s highlights, the challenges and opportunities in breast reconstruction, and the growing role of multidisciplinary collaboration. His insights provide valuable guidance for the evolution of the breast specialty and the training of young physicians.Key Highlights of the 2025 Conference
Prof. Haibo Wang: This year’s conference retained its hallmark sessions, such as expert debates and the signature “Langya Forum,” while introducing several new and impactful elements. Notably, we added a dedicated breast surgery track and a hands-on Qingdao Breast Reconstruction Training Course. On September 10, the course focused on “Minimally Invasive Endoscopic Techniques,” featuring live demonstrations and lectures by Professor Zhenggui Du (West China Hospital, Sichuan University), Professor Peng Tang (Southwest Hospital, Army Medical University), and Professor Zihan Wang (Beijing Chaoyang Hospital, Capital Medical University). Professor Haiyan Li (The Sixth Affiliated Hospital, Sun Yat-sen University) also shared practical strategies for adopting and advancing robotic-assisted breast surgery. On September 11, the focus shifted to “Advanced Reconstructive Surgery—Free Flaps and Oncoplastic Techniques,” with interactive workshops led by Professor Jiong Wu (Fudan University Cancer Hospital) and Professor Hongyuan Li (First Affiliated Hospital, Chongqing Medical University). These practical sessions, closely aligned with clinical needs, will accelerate the development of breast surgery skills across the region. Additionally, multiple specialized tracks were held, covering clinical trials, HER2-positive and HER2-low breast cancer, translational research, HR-positive breast cancer, and triple-negative breast cancer. These sessions were designed to strengthen the research and innovation capacity of young clinicians. Importantly, the conference collaborated with national and international programs such as the CSCO BC Guideline Tour and the CBCS & CSOBO Presidium Tour, expanding its academic influence and providing a world-class platform for knowledge exchange—ultimately benefiting patients.
Breast Reconstruction: Challenges and Opportunities in China
Prof. Haibo Wang: Breast reconstruction plays a crucial role, particularly for patients who wish to preserve their body image but are not suitable candidates for breast-conserving surgery. These techniques allow for restoration of form while ensuring oncologic safety, helping patients reintegrate both physically and psychologically. Reconstruction is now widely recognized in China as a vital component of breast cancer care. Techniques include immediate and delayed reconstruction, using implants, autologous tissue flaps, or a combination of the two. Minimally invasive approaches, including endoscopic and robotic techniques, are increasingly used, and microsurgical free flap procedures have largely replaced earlier pedicled flap methods. The goal is to eradicate disease while preserving or recreating the natural breast shape, improving patients’ confidence and quality of life. Leaders in both breast surgery (such as Professors Jiong Wu and Jian Yin) and plastic surgery (such as Professor Jiasheng Dong) have been instrumental in integrating oncologic and reconstructive techniques. Through continuous academic exchange, innovative ideas and techniques continue to emerge, driving steady progress in this field.
The Value of Multidisciplinary Collaboration and Training the Next Generation
Prof. Haibo Wang: We advocate a patient-centered, multidisciplinary model of cancer care that provides one-stop, streamlined services. At the Qingdao University Affiliated Hospital Breast Center, established in 2012, we have integrated breast surgery, medical oncology, plastic surgery, and rehabilitation, alongside radiation oncology, pathology, and nuclear medicine—creating a true one-stop model for diagnosis and treatment. The multidisciplinary team (MDT) approach improves physicians’ understanding of the entire disease trajectory and enables full-process management, from early screening and standardized diagnosis to personalized treatment planning. Early-stage cases can be managed with surgery-led treatment plans, while advanced or recurrent cases transition seamlessly to systemic therapy, with pathology and imaging providing essential baseline and response assessments. Rehabilitation teams follow patients long-term, ensuring continuous support and guidance. This approach enhances not only treatment outcomes but also the patient experience, addressing psychological health and supporting reintegration into daily life. For young physicians, participating in such comprehensive meetings is invaluable—it broadens their vision, hones clinical decision-making skills, and strengthens their ability to collaborate across disciplines.
About the Expert
Prof. Haibo Wang MD, Chief Physician, Doctoral Supervisor Director, Breast Disease Hospital, Affiliated Hospital of Qingdao University
